John Kiely - 22 Nov 2024 Form 4 Insider Report for Amneal Pharmaceuticals, Inc. (AMRX)

Role
Director
Signature
/s/ Denis Butkovic, Attorney-in-Fact
Issuer symbol
AMRX
Transactions as of
22 Nov 2024
Net transactions value
-$7,257
Form type
4
Filing time
26 Nov 2024, 16:41:27 UTC
Previous filing
14 May 2024
Next filing
08 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMRX Class A Common Stock Options Exercise $135,689 +28,506 +11% $4.76 284,233 22 Nov 2024 Direct
transaction AMRX Class A Common Stock Sale $142,946 -17,058 -6% $8.38 267,175 22 Nov 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMRX Stock Option Options Exercise $0 -28,506 -100% $0.000000 0 22 Nov 2024 Class A Common Stock 28,506 $4.76 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects shares sold to cover the exercise price arising in connection with the exercise of the stock options.
F2 The option is vested and currently exercisable.